144 ·Filed May 21, 2026

PHVS

Pharvaris N.V.
NEUTRAL
Impact 3/10
Horizondays Processed4mo ago SEC0001950047-26-004931
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

The insider sale is small in absolute terms, but the recent cluster of insider selling (4 sells in 30 days) warrants monitoring for any upcoming negative catalysts or data readouts. Watch for any material news or clinical trial updates that could explain the pattern.

DirectionNeutral
Confidencemedium
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
PHVS ▲ +21.63% at T+60d
NEUTRAL call ✓ call won +21.63% · α vs SPY +18.44% · entry $29.68 → $36.10
Entry anchored
May 21, 2026
via day open
T+1d
+0.67%
call +0.67% · α +0.09%
$29.88
settled 4mo ago
T+5d
-1.95%
call -1.95% · α -3.61%
$29.10
settled 4mo ago
T+20d
+9.47%
call +9.47% · α +10.88%
$32.49
settled 3mo ago
T+60d
+21.63%
call +21.63% · α +18.44%
$36.10
settled 6w ago

Price Chart

Loading chart...

Executive Summary

Director David W. Nassif filed a Form 144 notice of intent to sell 10,000 common shares of Pharvaris N.V., with an estimated aggregate market value of $303,076. The shares were acquired as restricted stock on April 15, 2025, and the proposed sale is planned for the Nasdaq exchange. This is a relatively small sale relative to the company's $2.1B market cap, but it comes amid a recent cluster of insider selling (4 sells totaling $786K in the past 30 days), which may raise modest concern about insider sentiment ahead of any upcoming catalysts.

Key Facts

  • Director David W. Nassif filed Form 144 to sell 10,000 shares of PHVS common stock.
  • Estimated aggregate market value of the proposed sale is $303,076.
  • Shares were acquired as restricted stock on April 15, 2025.
  • Proposed sale is planned for execution on or after May 21, 2026, on the Nasdaq exchange.
  • This filing follows 4 insider sells totaling $786K in the past 30 days.
  • The sale represents a small fraction of the company's $2.1B market cap.

Financial Impact

Proposed sale of $303,076 in shares, representing approximately 0.014% of the company's $2.1B market cap.

dilutioninsider ownership

Risk Factors

  • Insider selling cluster may signal reduced confidence ahead of a catalyst.
  • Form 144 is only an intent to sell; the sale may not be executed.
  • No specific share price or valuation context provided for the proposed sale.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (20 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-004931
Document: 0001950047-26-004931-index.html0001950047-26-004931
Document: 0001950047-26-004931.txt0001950047-26-004931
37 reports for PHVS
Performance horizon
90% Hit rate 9 of 10 directional calls best @ T+60▲ +21.31%Mar 20, 2026
Filters
Rows
Reports for PHVS — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
BEARISH ★ 5/10
$38.06 $36.37▲ +4.44%▲ +5.26%$31.19 (+18.05%)
Sep 14, 2026
17d ago
144
NEUTRAL ★ 2/10
$38.06 $35.20▼ −7.51%▼ −9.63%$31.19 (−18.05%)
Sep 14, 2026
18d ago
Insider Cluster
NEUTRAL ★ 3/10
$38.86 $36.02▼ −7.31%▼ −7.41%$31.19 (−19.74%)
Sep 11, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$38.02 $36.37▼ −4.34%▼ −4.12%$31.19 (−17.96%)
Sep 8, 2026
24d ago
6-K
BULLISH ★ 8/10
$37.84 $38.86▲ +2.70%▲ +3.36%$31.19 (−17.57%)
Aug 12, 2026
7w ago
6-K
NEUTRAL ★ 6/10
$36.46 $36.27▼ −0.52%▼ −0.08%$31.19 (−14.45%)
Aug 12, 2026
7w ago
Press Release
BULLISH ★ 7/10
$36.46 $36.27▼ −0.52%▼ −0.08%$31.19 (−14.45%)
Aug 6, 2026
8w ago
Press Release
NEUTRAL ★ 4/10
$34.45 $34.04▼ −1.19%▼ −2.40%$31.19 (−9.46%)
Jul 6, 2026
12w ago
Press Release
BULLISH ★ 6/10
$33.22 $35.07▲ +5.57%▲ +5.08%$31.19 (−6.11%)
Jul 1, 2026
13w ago
Insider Cluster
NEUTRAL ★ 3/10
$33.86 $35.96▲ +6.20%▲ +5.27%$31.19 (−7.89%)
Showing 10 of 37

US Market Status

Market Closed — Opens Mon (65h 26m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access